Global  Video

“The world's speediest news portal”
One News Page
> >

Immune therapy doubles lung cancer survival rate

bizjournals Tuesday, 17 April 2018 ()
New drugs that trigger a patient’s immune system to kill malignant cells can greatly improve the survival rate of people with the most common type of lung cancer, a new study found. The study, published in the New England Journal of Medicine, found that patients treated with the checkpoint inhibitor pembrolizumab, or Keytruda, made by Merck, along with chemotherapy  were 51 percent less likely to die compared with patients that only received chemotherapy, The Washington Post reports. The study…
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 
Source: Wochit News - < > Embed
News video: Lung Cancer Patients Fair Better with Immune Therapy

▶ Lung Cancer Patients Fair Better with Immune Therapy 00:45

According to a new report, lung cancer patients live longer while on immune therapy. Using a combination of immunotherapy drugs, doctors found that pre-treating lung cancer patients before surgery can help eat away at tumors, while helping patients recover from the affects of chemotherapy. A lung...

You Might Like


Recent related news

Immune therapy scores big win against lung cancer in study

CHICAGO (AP) — New research suggests that many more lung cancer patients may benefit from treatments that boost the immune system, which have scored some of...
SeattlePI.com - Health

Merck shares pop as its Keytruda drug results power ahead of Bristol-Myers, Roche

Merck & Co (NYSE:MRK), Bristol-Myers Squibb (NYSE:BMY) and Roche Holding AG (VTX: ROG) cancer drugs all beat expectations, but Merck beat them a little more...
Proactive Investors - Business

Immune therapy scores big win against lung cancer in study

CHICAGO (AP) — New research suggests that many more lung cancer patients may benefit from treatments that boost the immune system, which have scored some of...
Seattle Times - Front Page

Combination therapy doubles survival in metastatic lung cancer

The immunotherapy drug pembrolizumab, combined with chemotherapy, doubles survival in patients with non-squamous non-small cell lung cancer (NSNSCLC) lacking...
Science Daily - Science

Lung Cancer Patients Live Longer With Immune Therapy

Adding immunotherapy to standard chemo treatments can halve the risk of death for people with the most common type of lung cancer, a new study shows.
NYTimes.com - US

Is whole-brain radiation still best for brain metastases from small-cell lung cancer?

A new study compares outcomes of 5,752 small-cell lung cancer patients who received whole-brain radiation therapy (WBRT) with those of 200 patients who received...
Science Daily - Science

Biothera Pharmaceuticals Presents Translational Data from Ongoing Clinical Trials Showing Imprime PGG in Combination with Merck’s KEYTRUDA® (pembrolizumab) Drives Innate and Adaptive Immune Responses in Tumors

EAGAN, Minn., April 16, 2018 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc. today announced the presentation of new translational data from ongoing phase 2...
GlobeNewswire - Press Releases

2 cancer drugmakers just presented key data about how new treatments work in lung cancer — and the markets picked a winner (MRK, BMY)

2 cancer drugmakers just presented key data about how new treatments work in lung cancer — and the markets picked a winner (MRK, BMY)
· *Two cancer drugmaker rivals presented data on Monday about how combinations of their drugs, which harness the body's immune system to treat cancer, worked in...
Business Insider - Business


Tweets about this


Other recent news in Business

Sky receives £22bn formal takeover offer from COMCASTCosta coffee to be split from WHITBREAD
Whitbread: Please make a fuss next time you opt for a break up like the one you're planning with COSTA COFFEETWITTER posts $664.9m in first quarter revenue
WHATSAPP to raise minimum age limit to 16 in EUBharti Airtel approves BHARTI INFRATEL, Indus Towers merger

Recent related videos

News video: New studies show hope in fighting lung cancer

▶ New studies show hope in fighting lung cancer 03:52

Doctors have a powerful new approach to fighting lung cancer, the leading cause of cancer deaths. Two studies released Monday show drugs that boosted patients' immune systems can dramatically improve..
Source: CBSN -

News video: Merck Expands Lead in Lung Cancer Therapy

▶ Merck Expands Lead in Lung Cancer Therapy 02:26

Apr.16 -- Merck & Co. is cementing its lead in lung cancer therapy, fending off rival Bristol-Myers Squibb Co. after new data that could reshape treatment of the deadly disease. Bloomberg's Taylor..
Source: Bloomberg Global Business -

News video: Immunotherapy Advances For Lung Cancer Patients

▶ Immunotherapy Advances For Lung Cancer Patients 00:32

According to Business Insider, "New cancer treatments that harness the body's immune system are ready to go mainstream... cancer drugmakers showed that the use of immunotherapy in combination with..
Source: Wochit -

News video: For Breast Cancer More Muscle Mass is Better for Survival

▶ For Breast Cancer More Muscle Mass is Better for Survival 00:39

According to a new study, breast cancer patients with more muscle mass have a higher rate of survival. The researchers also found that age-related muscle loss and fat were linked to a lower survival..
Source: Wochit -

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2018 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+